Overview

BLOSSOM: Behavioral Modification and Lorcaserin Second Study for Obesity Management

Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the weight loss effect of lorcaserin during and at the end of 1 year of treatment in overweight and obese patients.
Phase:
Phase 3
Details
Lead Sponsor:
Arena Pharmaceuticals
Eisai Inc.